Form 4: Procept BioRobotics EVP, CFO Kevin Waters Executes Stock Options and Sells Shares
SEC Form 4
Kevin Waters, EVP and CFO of Procept BioRobotics, exercised stock options and sold shares of common stock on September 16, 2024, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On September 16, 2024, Kevin Waters, the EVP and CFO of Procept BioRobotics Corp, executed stock options to acquire shares of common stock.
- Waters acquired 15,917 shares at $4.52 and 9,083 shares at $4.56.
- Concurrently, Waters sold 6,623 shares at a weighted average price of $81.96, 17,977 shares at a weighted average price of $82.69, and 400 shares at a weighted average price of $83.35.
- These transactions were executed under a Rule 10b5-1 trading plan adopted on June 13, 2024.
- Following these transactions, Waters directly owns 96,096 shares of Procept BioRobotics Corp.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of insider trading activity. The transactions are part of a pre-planned trading strategy, so it doesn't necessarily indicate a positive or negative outlook on the company.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions. It's common for executives to exercise stock options and sell shares, often under pre-arranged trading plans like Rule 10b5-1, to manage personal finances.
Comparison to Industry Standards
- Insider trading activity is closely monitored in the biotech and medical device industries, similar to other sectors.
- Companies like Intuitive Surgical and Stryker are also subject to similar insider trading regulations and reporting requirements.
- The use of Rule 10b5-1 trading plans is a common practice among executives in publicly traded companies to avoid accusations of trading on inside information.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the pre-planned nature of the trades mitigates concerns about insider information being used.
Key Dates
| Date | Description |
|---|---|
| October 23, 2018 | Date the stock option for 15,917 shares was granted, vesting over four years. |
| December 12, 2019 | Date the stock option for 9,083 shares was granted, vesting over four years. |
| June 13, 2024 | Date the Rule 10b5-1 trading plan was adopted by Kevin Waters. |
| September 16, 2024 | Date of the stock option exercises and share sales. |
| October 22, 2028 | Expiration date of the stock option for 15,917 shares. |
| December 11, 2029 | Expiration date of the stock option for 9,083 shares. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.